e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Basic and translational studies in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of interferon-γ in tumor necrosis factor-α-mediated increase of lung microvascular endothelial cells
Y. Nakajima, Y. Nakamura, N. Suzuki, Y. Utsumi, N. Sasaki, K. Yamauchi (Morioka, Japan)
Source:
Annual Congress 2012 - Basic and translational studies in COPD
Session:
Basic and translational studies in COPD
Session type:
Poster Discussion
Number:
1428
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Nakajima, Y. Nakamura, N. Suzuki, Y. Utsumi, N. Sasaki, K. Yamauchi (Morioka, Japan). Role of interferon-γ in tumor necrosis factor-α-mediated increase of lung microvascular endothelial cells. Eur Respir J 2012; 40: Suppl. 56, 1428
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Imbalance between vascular endothelial growth factor and endostatin in emphysema
Source: Eur Respir J 2003 Oct 01;22(4):609-612
Year: 2003
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Source: Eur Respir J 2002; 20: 1449-1456
Year: 2002
Hypoxia-induced increase in NO production and eNOS expression by murine pulmonary microvascular endothelial cells
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Effect of BMPRII on endothelial function in human lung microvascular endothelial cells
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Decreased VEGF concentration in lung tissue and vascular injury during ARDS
Source: Eur Respir J 2005; 25: 139-146
Year: 2005
Implication of aquaporin-1 in the stress response of human pulmonary microvascular endothelial cells
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary microvascular endothelial (HMVEC-l) cells
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Vascular endothelial growth factor (VEGF) isoform expression in primary human cultured alveolar epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 84s
Year: 2003
Circulating fibrocytes depletion results in reduced lung tumor growth and metastasis by modulating macrophage phenotype, angiogenesis and endothelin system
Source: ERS Lung Science Conference 2017
Year: 2017
Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD
Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Year: 2007
Co-culturing alveolar epithelial with lung micro-vascular endothelial cells attenuates hypoxia-induced alveolar leakage and inhibition of reabsorption
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009
Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells
Source: Annual Congress 2003 - Cell signalling and cytokines in asthma
Year: 2003
Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease
in vitro
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Role of vascular endotelial growth factor polymorphisms in interstitial lung disease
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept